Clinical trial Recruiting at 1 site Observational Ages 18 and up

Examining biomarkers in patients with acute cerebral hypoxia

Official title: Thrombo-inflammation Biomarkers Trial in Acute Cerebral Hypoxia. A Case-control Trial Nested in a Cohort

Run by Fondation Ophtalmologique Adolphe de Rothschild · NCT04971564 · Data updated 2026-11-12

This study is testing the levels of certain inflammation markers in patients with acute brain oxygen loss from conditions like stroke and bleeding in the brain to see how they compare to those without these issues.

More Ischemic Stroke trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorFondation Ophtalmologique Adolphe de Rothschild
Research network
Locations1 site (Paris, Île-de-France Region)
StatusRecruiting
StartedMarch 19, 2024
Main results expectedJune 18, 2028
Study endsSeptember 18, 2028
Registry record updatedNovember 9, 2026
Trial IDNCT04971564 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients admitted within 36 hours of acute neurological symptoms related to ischemic stroke, subarachnoid hemorrhage, or intra-parenchymal hematoma.

Probably not a fit

Patients with pre-existing disabilities, those under legal protection, pregnant or breastfeeding women, and individuals with secondary hemorrhagic transformation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational trial aims to investigate the levels of thrombo-inflammation biomarkers in patients experiencing acute cerebral hypoxia due to specific conditions such as ischemic stroke, subarachnoid hemorrhage, and intra-parenchymal hematoma. It compares these biomarker concentrations to those in a control group of patients without cerebral hypoxia. Additionally, the study will explore the relationship between biomarker levels and clinical outcomes in patients with cerebral hypoxia. Blood samples will be collected for analysis.

Why it matters

Potential benefit: If successful, this study could enhance understanding of thrombo-inflammation in cerebral hypoxia, potentially leading to improved diagnostic and therapeutic strategies.

How similar studies have gone: While this approach is focused on specific biomarkers in acute cerebral hypoxia, similar studies have shown promise in understanding thrombo-inflammation in other neurological conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

\- For cases, admitted within the first 36 hours of an acute neurological symptom related to :

* An ischaemic cerebrovascular accident (iCVA) eligible for a mechanical thrombectomy procedure,
* A subarachnoid haemorrhage (SAH, all aetiologies) : patient presenting with at least a modified Fisher scale 3 or 4,
* An intra-parenchymal haematoma (IPH) with greatest axis ≥ 20mm or with NIHSS on admission \>4.

OR

* For control patients, admitted within 7 days of the onset of acute neurological symptomatology related to a clinical diagnosis of transient ischaemic attack (TIA) - based on thorough questioning of the patient on admission - and prior to imaging, with an ABCD2≥ 2 score.
* Express consent to participate in the study.
* Member or beneficiary of a social security.

Exclusion Criteria:

* Pre-existing functional and/or cognitive disability
* Patient under legal protection.
* Pregnant or breastfeeding woman.
* Patient with secondary haemorrhagic transformation.

Secondary exclusion criteria :

* Patients with an ischaemic lesion visible on imaging, unrelated to large vessel occlusion and therefore ineligible for mechanical thrombectomy.
* Patients diagnosed with an acute non-vascular neurological pathology (migraine, epilepsy, etc.).
* TIA patients presenting an abnormality on follow-up imaging 24-48 hours after the initial imaging.

Excluded patients will be replaced.

Where it's running

  • Hôpital Fondation Adolphe de Rothschild
    Paris, Île-de-France Region, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals

    This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.

    Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Leuven and 6 other locations · NCT07924371

  • Remote ischemic conditioning for post-stroke insomnia

    A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.

    Recruiting Sichuan Academy of Medical Sciences · Chengdu, Sichuan · NCT07874594

  • Ear-based nerve stimulation to help sleep after a stroke

    A device that delivers vagal nerve stimulation through the ear is tested to see if it helps stroke patients in rehab sleep better.

    Recruiting Casa Colina Hospital and Centers for Healthcare · Pomona, California · NCT07858656

  • Theta Burst Stimulation to Help Stroke Recovery (Upper and Lower Limbs)

    This trial tests whether applying theta burst stimulation to the motor cortex, in combination with standard rehabilitation, helps people over 45 who recently had a first ischemic stroke recover arm and leg movement.

    Recruiting Ankara Etlik City Hospital · Ankara, Yenimahalle · NCT07834333

  • Preventing another ischemic stroke with a smart bracelet and app

    This study tests whether a digital prevention program using a wearable and a mobile app can help people who recently had an ischemic stroke reduce the chance of another stroke and improve risk-factor control.

    Recruiting Affiliated Hospital of Nantong University · Nantong, Jiangsu · NCT07825311

  • Photon-counting CT to check intracranial stents

    This study tests whether ultra-high-resolution photon-counting CT can reliably visualize intracranial stents and detect in-stent restenosis during follow-up of patients with prior stents.

    Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07769814

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.